Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2016 Apr;37(4):265-8.
doi: 10.3760/cma.j.issn.0253-2727.2016.04.001.

[Chinese expert consensus on the diagnosis and treatment of polycythemia vera (2016)]

[Article in Chinese]
Leukemia and Lymphoma Group, Chinese Society of Hematology, Chinese Medical Association

[Chinese expert consensus on the diagnosis and treatment of polycythemia vera (2016)]

[Article in Chinese]
Leukemia and Lymphoma Group, Chinese Society of Hematology, Chinese Medical Association. Zhonghua Xue Ye Xue Za Zhi. 2016 Apr.
No abstract available

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

References

    1. 徐 俊卿, 徐 泽锋, 王 静雅, et al. 615例Ph染色体/BCR-ABL融合基因阴性骨髓增殖性肿瘤患者的症状负荷评估[J] 中华血液学杂志. 2016;37(1):26–29. doi: 10.3760/cma.j.issn.0253-2727.2016.01.005. - DOI - PubMed
    1. Barbui T, Barosi G, Birgegard G, et al. Philadelphia-negative classical myeloproliferative neoplasms: critical Concepts and management recommendations from European LeukemiaNet[J] J Clin Oncol. 2011;29(6):761–770. doi: 10.1200/JCO.2010.31.8436. - DOI - PMC - PubMed
    1. Scott LM, Tong W, Levine RL, et al. JAK2 exon 12 mutations in polycythemia vera and idiopathic erythrocytosis[J] N Engl J Med. 2007;356(5):459–468. doi: 10.1056/NEJMoa065202. - DOI - PMC - PubMed
    1. Bench AJ, White HE, Foroni L, et al. Molecular diagnosis of the myeloproliferative neoplasms: UK guidelines for the detection of JAK2 V617F and other relevant mutations[J] Br J Haematol. 2013;160(1):25–34. doi: 10.1111/bjh.12075. - DOI - PubMed
    1. 肖 志坚. 骨髓增殖性肿瘤和骨髓增生异常综合征/骨髓增殖性肿瘤:开启分子诊断新时代[J] 中华血液学杂志. 2014;35(5):385–386. doi: 10.3760/cma.j.issn.0253-2727.2014.05.001. - DOI - PubMed